Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Biopsy Forceps, Transbronchial Needle Aspiration Needles, Cytology Brushes, Cryobiopsy Devices), By Region, And Segment Forecasts, 2024 - 2030
This report can be delivered to the clients within 2 Business Days
Breast Ultrasound Market Growth & Trends
The global breast ultrasound market size is anticipated to reach USD 5.02 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.2% from 2024 to 2030. Various factors such as high prevalence of breast cancer, various awareness initiatives, and rapid technological advancements are expected to propel the market growth.
Governments and non-profit organizations from around the world engage in various initiatives to raise awareness regarding breast cancer. The aim of these initiatives is to highlight the importance of awareness and early diagnosis and to raise funds to support research on breast cancer. For instance, Breast Cancer Awareness is a worldwide annual awareness campaign organized by thousands of organizations in the month of October. The aim of this campaign is to raise awareness and raise funds for breast cancer research.
Similarly, the National Breast Cancer Foundation (NBCF) organizes various programs, such as Breast Cancer Awareness and National Mammography Program, to encourage early detection, education, and support services. Under the National Mammography Program, NBCF has also partnered with various medical facilities in U.S. to provide free breast cancer diagnosis services to the underserved women in the country.
Such initiatives are expected to increase the demand for various imaging techniques for the screening of breast cancer, thereby, boosting the market growth. Moreover, supportive reimbursement policies for breast cancer diagnosis and treatment is also anticipated to boost the breast ultrasound market growth over the forecast period.
Breast Ultrasound Market Report Highlights
Breast Ultrasound Market Growth & Trends
The global breast ultrasound market size is anticipated to reach USD 5.02 billion by 2030, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 14.2% from 2024 to 2030. Various factors such as high prevalence of breast cancer, various awareness initiatives, and rapid technological advancements are expected to propel the market growth.
Governments and non-profit organizations from around the world engage in various initiatives to raise awareness regarding breast cancer. The aim of these initiatives is to highlight the importance of awareness and early diagnosis and to raise funds to support research on breast cancer. For instance, Breast Cancer Awareness is a worldwide annual awareness campaign organized by thousands of organizations in the month of October. The aim of this campaign is to raise awareness and raise funds for breast cancer research.
Similarly, the National Breast Cancer Foundation (NBCF) organizes various programs, such as Breast Cancer Awareness and National Mammography Program, to encourage early detection, education, and support services. Under the National Mammography Program, NBCF has also partnered with various medical facilities in U.S. to provide free breast cancer diagnosis services to the underserved women in the country.
Such initiatives are expected to increase the demand for various imaging techniques for the screening of breast cancer, thereby, boosting the market growth. Moreover, supportive reimbursement policies for breast cancer diagnosis and treatment is also anticipated to boost the breast ultrasound market growth over the forecast period.
Breast Ultrasound Market Report Highlights
- On the basis of product, Automated breast ultrasound (ABUS) segment dominated the market and accounted for a share of 64.1% in 2023 owing to the availability of many products, rapid technological advancements, regulatory approvals, and user-friendly features of this device.
- Hospital segment held the largest market share in 2023 owing to the rising prevalence of breast cancer
- Asia Pacific breast ultrasound market is anticipated to witness the fastest growth over the forecast period owing to the growing awareness regarding the disease and its treatment procedures
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising utilization of bronchial biopsies for diagnosing lung cancer and related conditions
3.2.1.2. Rising adoption of disposable devices
3.2.1.3. Rapid technological advancements
3.2.1.4. Increasing awareness and screening initiatives by organizations
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of alternative solutions
3.2.3. Market Opportunity Analysis
3.2.4. Market Threat Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. PRODUCT BUSINESS ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Biopsy Forceps
4.4.1. Bronchial biopsy forceps market, by durability, 2018 - 2030 (USD Million)
4.4.2. Disposable
4.4.2.1. Disposable market, 2018 - 2030 (USD Million)
4.4.3. Reusable
4.4.3.1. Disposable market, 2018 - 2030 (USD Million)
4.5. Transbronchial needle aspiration (TBNA) needles
4.5.1. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
4.5.2. Conventional
4.5.2.1. Conventional market, 2018 - 2030 (USD Million)
4.5.3. EBUS-TBNA
4.5.3.1. EBUS-TBNA market, 2018 - 2030 (USD Million)
4.6. Cytology Brushes
4.6.1. Cytology brushes market, 2018 - 2030 (USD Million)
4.7. Cryobiopsy Devices
4.7.1. Cryobiopsy devices market, by durability, 2018 - 2030 (USD Million)
4.7.2. Disposable
4.7.2.1. Disposable market, 2018 - 2030 (USD Million)
4.7.3. Reusable
4.7.3.1. Disposable market, 2018 - 2030 (USD Million)
CHAPTER 5. REGIONAL ESTIMATES & TREND ANALYSIS BY COMPONENT
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.4. North America
5.4.1. North America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. U.S.
5.4.2.1. Key country dynamic
5.4.2.2. Regulatory framework/reimbursement scenario
5.4.2.3. U.S. bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Canada
5.4.3.1. Key country dynamic
5.4.3.2. Regulatory framework/reimbursement scenario
5.4.3.3. Canada bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. Mexico
5.4.4.1. Key country dynamic
5.4.4.2. Regulatory framework/reimbursement scenario
5.4.4.3. Mexico bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Europe
5.5.1. Europe bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. UK
5.5.2.1. Key country dynamic
5.5.2.2. Regulatory framework/reimbursement scenario
5.5.2.3. UK bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Germany
5.5.3.1. Key country dynamic
5.5.3.2. Regulatory framework/reimbursement scenario
5.5.3.3. Germany bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. France
5.5.4.1. Key country dynamic
5.5.4.2. Regulatory framework/reimbursement scenario
5.5.4.3. France bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.5. Italy
5.5.5.1. Key country dynamic
5.5.5.2. Regulatory framework/reimbursement scenario
5.5.5.3. Italy bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.6. Spain
5.5.6.1. Key country dynamic
5.5.6.2. Regulatory framework/reimbursement scenario
5.5.6.3. Spain bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.7. Norway
5.5.7.1. Key country dynamic
5.5.7.2. Regulatory framework/reimbursement scenario
5.5.7.3. Norway bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamic
5.5.8.2. Regulatory framework/reimbursement scenario
5.5.8.3. Denmark bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.9. Sweden
5.5.9.1. Key country dynamic
5.5.9.2. Regulatory framework/reimbursement scenario
5.5.9.3. Sweden bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key country dynamic
5.6.2.2. Regulatory framework/reimbursement scenario
5.6.2.3. Japan bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. China
5.6.3.1. Key country dynamic
5.6.3.2. Regulatory framework/reimbursement scenario
5.6.3.3. China bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.4. India
5.6.4.1. Key country dynamic
5.6.4.2. Regulatory framework/reimbursement scenario
5.6.4.3. India bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamic
5.6.5.2. Regulatory framework/reimbursement scenario
5.6.5.3. South Korea bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.6. Australia
5.6.6.1. Key country dynamic
5.6.6.2. Regulatory framework/reimbursement scenario
5.6.6.3. Australia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.7. Thailand
5.6.7.1. Key country dynamic
5.6.7.2. Regulatory framework/reimbursement scenario
5.6.7.3. Thailand bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Latin America
5.7.1. Latin America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.2. Brazil
5.7.2.1. Key country dynamic
5.7.2.2. Regulatory framework/reimbursement scenario
5.7.2.3. Brazil bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.3. Argentina
5.7.3.1. Key country dynamic
5.7.3.2. Regulatory framework/reimbursement scenario
5.7.3.3. Argentina bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. MEA
5.8.1. MEA bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.2. South Africa
5.8.2.1. Key country dynamic
5.8.2.2. Regulatory framework/reimbursement scenario
5.8.2.3. South Africa bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.3. Saudi Arabia
5.8.3.1. Key country dynamic
5.8.3.2. Regulatory framework/reimbursement scenario
5.8.3.3. Saudi Arabia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.4. UAE
5.8.4.1. Key country dynamic
5.8.4.2. Regulatory framework/reimbursement scenario
5.8.4.3. UAE bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.5. Kuwait
5.8.5.1. Key country dynamic
5.8.5.2. Regulatory framework/reimbursement scenario
5.8.5.3. Kuwait bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. Medtronic
6.5.1.1. Overview
6.5.1.2. Financial performance
6.5.1.3. Product benchmarking
6.5.1.4. Strategic initiatives
6.5.2. Boston Scientific Corporation
6.5.2.1. Overview
6.5.2.2. Financial performance
6.5.2.3. Product benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Cook Medical
6.5.3.1. Overview
6.5.3.2. Financial performance
6.5.3.3. Product benchmarking
6.5.3.4. Strategic initiatives
6.5.4. CONMED Corporation
6.5.4.1. Overview
6.5.4.2. Financial performance
6.5.4.3. Product benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Telemed Systems, Inc.
6.5.5.1. Overview
6.5.5.2. Financial performance
6.5.5.3. Product benchmarking
6.5.5.4. Strategic initiatives
6.5.6. HOBBS MEDICAL INC
6.5.6.1. Overview
6.5.6.2. Financial performance
6.5.6.3. Product benchmarking
6.5.6.4. Strategic initiatives
6.5.7. Becton, Dickinson and Company (BD)
6.5.7.1. Overview
6.5.7.2. Financial performance
6.5.7.3. Product benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Olympus Corporation
6.5.8.1. Overview
6.5.8.2. Financial performance
6.5.8.3. Product benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Horizons International Corp.
6.5.9.1. Overview
6.5.9.2. Financial performance
6.5.9.3. Product benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Argon Medical Devices
6.5.10.1. Overview
6.5.10.2. Financial performance
6.5.10.3. Product benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Erbe Elektromedizin GmbH
6.5.11.1. Overview
6.5.11.2. Financial performance
6.5.11.3. Product benchmarking
6.5.11.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising utilization of bronchial biopsies for diagnosing lung cancer and related conditions
3.2.1.2. Rising adoption of disposable devices
3.2.1.3. Rapid technological advancements
3.2.1.4. Increasing awareness and screening initiatives by organizations
3.2.2. Market Restraint Analysis
3.2.2.1. Availability of alternative solutions
3.2.3. Market Opportunity Analysis
3.2.4. Market Threat Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis – Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.3. COVID-19 Impact Analysis
CHAPTER 4. PRODUCT BUSINESS ANALYSIS
4.1. Product Market Share, 2023 & 2030
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. Biopsy Forceps
4.4.1. Bronchial biopsy forceps market, by durability, 2018 - 2030 (USD Million)
4.4.2. Disposable
4.4.2.1. Disposable market, 2018 - 2030 (USD Million)
4.4.3. Reusable
4.4.3.1. Disposable market, 2018 - 2030 (USD Million)
4.5. Transbronchial needle aspiration (TBNA) needles
4.5.1. Transbronchial needle aspiration (TBNA) needles market, 2018 - 2030 (USD Million)
4.5.2. Conventional
4.5.2.1. Conventional market, 2018 - 2030 (USD Million)
4.5.3. EBUS-TBNA
4.5.3.1. EBUS-TBNA market, 2018 - 2030 (USD Million)
4.6. Cytology Brushes
4.6.1. Cytology brushes market, 2018 - 2030 (USD Million)
4.7. Cryobiopsy Devices
4.7.1. Cryobiopsy devices market, by durability, 2018 - 2030 (USD Million)
4.7.2. Disposable
4.7.2.1. Disposable market, 2018 - 2030 (USD Million)
4.7.3. Reusable
4.7.3.1. Disposable market, 2018 - 2030 (USD Million)
CHAPTER 5. REGIONAL ESTIMATES & TREND ANALYSIS BY COMPONENT
5.1. Regional Market Share Analysis, 2023 & 2030
5.2. Regional Market Dashboard
5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
5.4. North America
5.4.1. North America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.2. U.S.
5.4.2.1. Key country dynamic
5.4.2.2. Regulatory framework/reimbursement scenario
5.4.2.3. U.S. bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.3. Canada
5.4.3.1. Key country dynamic
5.4.3.2. Regulatory framework/reimbursement scenario
5.4.3.3. Canada bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.4.4. Mexico
5.4.4.1. Key country dynamic
5.4.4.2. Regulatory framework/reimbursement scenario
5.4.4.3. Mexico bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Europe
5.5.1. Europe bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.2. UK
5.5.2.1. Key country dynamic
5.5.2.2. Regulatory framework/reimbursement scenario
5.5.2.3. UK bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.3. Germany
5.5.3.1. Key country dynamic
5.5.3.2. Regulatory framework/reimbursement scenario
5.5.3.3. Germany bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.4. France
5.5.4.1. Key country dynamic
5.5.4.2. Regulatory framework/reimbursement scenario
5.5.4.3. France bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.5. Italy
5.5.5.1. Key country dynamic
5.5.5.2. Regulatory framework/reimbursement scenario
5.5.5.3. Italy bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.6. Spain
5.5.6.1. Key country dynamic
5.5.6.2. Regulatory framework/reimbursement scenario
5.5.6.3. Spain bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.7. Norway
5.5.7.1. Key country dynamic
5.5.7.2. Regulatory framework/reimbursement scenario
5.5.7.3. Norway bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.8. Denmark
5.5.8.1. Key country dynamic
5.5.8.2. Regulatory framework/reimbursement scenario
5.5.8.3. Denmark bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.5.9. Sweden
5.5.9.1. Key country dynamic
5.5.9.2. Regulatory framework/reimbursement scenario
5.5.9.3. Sweden bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6. Asia Pacific
5.6.1. Asia Pacific bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.2. Japan
5.6.2.1. Key country dynamic
5.6.2.2. Regulatory framework/reimbursement scenario
5.6.2.3. Japan bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.3. China
5.6.3.1. Key country dynamic
5.6.3.2. Regulatory framework/reimbursement scenario
5.6.3.3. China bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.4. India
5.6.4.1. Key country dynamic
5.6.4.2. Regulatory framework/reimbursement scenario
5.6.4.3. India bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.5. South Korea
5.6.5.1. Key country dynamic
5.6.5.2. Regulatory framework/reimbursement scenario
5.6.5.3. South Korea bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.6. Australia
5.6.6.1. Key country dynamic
5.6.6.2. Regulatory framework/reimbursement scenario
5.6.6.3. Australia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.6.7. Thailand
5.6.7.1. Key country dynamic
5.6.7.2. Regulatory framework/reimbursement scenario
5.6.7.3. Thailand bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.7. Latin America
5.7.1. Latin America bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.2. Brazil
5.7.2.1. Key country dynamic
5.7.2.2. Regulatory framework/reimbursement scenario
5.7.2.3. Brazil bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.7.3. Argentina
5.7.3.1. Key country dynamic
5.7.3.2. Regulatory framework/reimbursement scenario
5.7.3.3. Argentina bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8. MEA
5.8.1. MEA bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.2. South Africa
5.8.2.1. Key country dynamic
5.8.2.2. Regulatory framework/reimbursement scenario
5.8.2.3. South Africa bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.3. Saudi Arabia
5.8.3.1. Key country dynamic
5.8.3.2. Regulatory framework/reimbursement scenario
5.8.3.3. Saudi Arabia bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.4. UAE
5.8.4.1. Key country dynamic
5.8.4.2. Regulatory framework/reimbursement scenario
5.8.4.3. UAE bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
5.8.5. Kuwait
5.8.5.1. Key country dynamic
5.8.5.2. Regulatory framework/reimbursement scenario
5.8.5.3. Kuwait bronchial biopsy devices market estimates and forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. COMPETITIVE LANDSCAPE
6.1. Participant Overview
6.2. Company Market Position Analysis
6.3. Company Categorization
6.4. Strategy Mapping
6.5. Company Profiles/Listing
6.5.1. Medtronic
6.5.1.1. Overview
6.5.1.2. Financial performance
6.5.1.3. Product benchmarking
6.5.1.4. Strategic initiatives
6.5.2. Boston Scientific Corporation
6.5.2.1. Overview
6.5.2.2. Financial performance
6.5.2.3. Product benchmarking
6.5.2.4. Strategic initiatives
6.5.3. Cook Medical
6.5.3.1. Overview
6.5.3.2. Financial performance
6.5.3.3. Product benchmarking
6.5.3.4. Strategic initiatives
6.5.4. CONMED Corporation
6.5.4.1. Overview
6.5.4.2. Financial performance
6.5.4.3. Product benchmarking
6.5.4.4. Strategic initiatives
6.5.5. Telemed Systems, Inc.
6.5.5.1. Overview
6.5.5.2. Financial performance
6.5.5.3. Product benchmarking
6.5.5.4. Strategic initiatives
6.5.6. HOBBS MEDICAL INC
6.5.6.1. Overview
6.5.6.2. Financial performance
6.5.6.3. Product benchmarking
6.5.6.4. Strategic initiatives
6.5.7. Becton, Dickinson and Company (BD)
6.5.7.1. Overview
6.5.7.2. Financial performance
6.5.7.3. Product benchmarking
6.5.7.4. Strategic initiatives
6.5.8. Olympus Corporation
6.5.8.1. Overview
6.5.8.2. Financial performance
6.5.8.3. Product benchmarking
6.5.8.4. Strategic initiatives
6.5.9. Horizons International Corp.
6.5.9.1. Overview
6.5.9.2. Financial performance
6.5.9.3. Product benchmarking
6.5.9.4. Strategic initiatives
6.5.10. Argon Medical Devices
6.5.10.1. Overview
6.5.10.2. Financial performance
6.5.10.3. Product benchmarking
6.5.10.4. Strategic initiatives
6.5.11. Erbe Elektromedizin GmbH
6.5.11.1. Overview
6.5.11.2. Financial performance
6.5.11.3. Product benchmarking
6.5.11.4. Strategic initiatives
